Alzheimer's, Parkinson's and type II diabetes: New way to target shape-shifting proteins

A molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified. The discovery could lead to new methods to identify drugs to prevent, treat or halt the progression of other conditions in which amyloid fibrils play a part, including Alzheimer's, Parkinson's and type II diabetes.

Read the whole article on Science Daily

More from Science Daily